Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Web-based data management for a phase II clinical trial in ALS.

Buchsbaum R, Kaufmann P, Barsdorf AI, Arbing R, Montes J, Thompson JL; QALS Study Group.

Amyotroph Lateral Scler. 2009 Oct-Dec;10(5-6):374-7. doi: 10.3109/17482960802378998.

PMID:
19922127
2.

Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III.

Kaufmann P, Thompson JL, Levy G, Buchsbaum R, Shefner J, Krivickas LS, Katz J, Rollins Y, Barohn RJ, Jackson CE, Tiryaki E, Lomen-Hoerth C, Armon C, Tandan R, Rudnicki SA, Rezania K, Sufit R, Pestronk A, Novella SP, Heiman-Patterson T, Kasarskis EJ, Pioro EP, Montes J, Arbing R, Vecchio D, Barsdorf A, Mitsumoto H, Levin B; QALS Study Group.

Ann Neurol. 2009 Aug;66(2):235-44. doi: 10.1002/ana.21743.

3.

Is erythropoietin a potential therapy for amyotrophic lateral sclerosis?

Butsch PO, Cudkowicz ME.

Exp Neurol. 2007 Jul;206(1):11-5. Epub 2007 Apr 11. Review. No abstract available.

PMID:
17498699
4.

[Differential malignant lymphoproliferative syndrome (LPS) diagnosis with flow cytometry: a study of 100 patients].

Cardile N, Sabo G, Butsch P, Brengarth E, Viollier AF, Knecht H.

Praxis (Bern 1994). 2000 Jan 20;89(4):143-9. German.

PMID:
10686807

Supplemental Content

Loading ...
Support Center